用語

Ad26.COV2.S(Janssen COVID-19 Vaccine)(用語-参考文系一覧)

 Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine  Sadoff J, Le Gars M, Shukarev G, et al. 〔N Engl J Med. 2021 May 13;384(19):1824-1835〕 Ad26.COV2.Sワクチンの第I/IIa相臨床試験の中間解析結果 (日本語概要)  Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19  Stephenson KE, Le Gars M, Sadoff J, et...

バキスゼブリア(Oxford/AstraZeneca COVID-19 vaccine, AZD1222)(用語-参考文系一覧)

 Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Ramasamy MN, Minassian AM, Ewer KJ, et al. 〔Lancet. 2021 Dec 19;396(10267):1979-1993〕若年成人および高齢者を対象としたChAdOx1 nCoV-19ワクチン2回接種の安全性と免疫原性(COV002) ― 単盲検無作為化比較第II/III相試験 (日本語概要) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in...

mRNA-1273(Moderna COVID-19 Vaccine)(用語-参考文系一覧)

 Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination (Correspondence)  Widge AT, Rouphael NG, Jackson LA, et al. 〔N Engl J Med. 2021 Jan 7;384(1):80-82〕 SARS-CoV-2ワクチンmRNA-1273接種後の反応の持続性(Editorへのレター) (日本語概要) Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine  Baden LR, El Sahly HM, Essink B, et al. 〔N Engl J...

トジナメラン(Pfizer-BioNTech vaccine BNT162b2)(用語-参考文系一覧)

 Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults.  Mulligan MJ, Lyke KE, Kitchin N, et al. 〔Nature. 2020 Oct;586(7830):589-593〕 成人でのCOVID-19 RNAワクチンBNT162b1の第I/II相試験 (日本語概要) Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates  Walsh EE, Frenck RW Jr, Falsey AR, et al. 〔N Engl J...

アスピリン(用語-参考文系一覧)

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial  RECOVERY Collaborative Group〔medRxiv. 2021 Jun 8〕 COVID-19入院患者に対するアスピリンの投与(RECOVERY試験) ― オープンラベル無作為化比較プラットフォーム試験 (日本語概要)
All countries
695,781,740
Total confirmed cases
Updated on 2023年9月26日 8:55 PM
Italy
26,043,870
Total confirmed cases
Updated on 2023年9月26日 8:55 PM
Spain
13,914,811
Total confirmed cases
Updated on 2023年9月26日 8:55 PM
Iran
7,615,822
Total confirmed cases
Updated on 2023年9月26日 8:55 PM
Germany
38,486,260
Total confirmed cases
Updated on 2023年9月26日 8:55 PM

Frequently Asked Questions